가입 후 초대 링크를 공유하면 동영상 재생 및 초대 보상을 받을 수 있습니다.

IPO Newsroom
@IPONewsroom_
Your IPO newsroom. S-1 filings, pricing updates, debut coverage, and post-IPO performance.
가입 November 2024
109 팔로잉 중    32K 팬
Samsung Biologics' $2 billion rights offering was oversubscribed more than five times, drawing bids for 11.9 million shares against 2.3 million offered. The proceeds help fund its acquisition of PolyPeptide, per Dow Jones.
더 보기